Risk of Upper Gastrointestinal Bleeding in a Cohort of New Users of Low-Dose ASA for Secondary Prevention of Cardiovascular Outcomes.
about
Gastrointestinal ulcers, role of aspirin, and clinical outcomes: pathobiology, diagnosis, and treatmentValidation of low-dose aspirin prescription data in The Health Improvement Network: how much misclassification due to over-the-counter use?Risk of uncomplicated peptic ulcer disease in a cohort of new users of low-dose acetylsalicylic acid for secondary prevention of cardiovascular eventsUse of aspirin for primary and secondary cardiovascular disease prevention in the United States, 2011-2012.The Protective Effect of Low-Dose Aspirin against Colorectal Cancer Is Unlikely Explained by Selection Bias: Results from Three Different Study Designs in Clinical PracticeBleeding Risk with Long-Term Low-Dose Aspirin: A Systematic Review of Observational Studies.Aspirin for cardioprotection and strategies to improve patient adherence.Management of low-dose aspirin and clopidogrel in clinical practice: a gastrointestinal perspective.Aspirin resistance and other aspirin-related concerns.Age-specific risks, severity, time course, and outcome of bleeding on long-term antiplatelet treatment after vascular events: a population-based cohort study.Low-dose acetylsalicylic acid use and the risk of upper gastrointestinal bleeding: a meta-analysis of randomized clinical trials and observational studies.
P2860
Q27027977-846CA976-6945-479D-A360-B0C7D1D09CA9Q31031802-6CD06D54-D413-4A66-9F71-DEBACDE7E90BQ34746758-A48621A4-CBE5-4C3D-A354-EF21A4F35ADAQ35026319-6661F2B9-9395-4386-87E5-6B998CD97303Q36079984-C97C4D6E-2A8C-40C9-B7A1-090EC443DA2EQ36094923-B6F53D05-5E45-46B9-8539-4C00A25400C7Q38176141-20AD923F-DB1E-4DAE-BDE0-64922CD43C82Q38321114-0CEF0D8F-3715-42AE-A5B8-5A1166C768D6Q38634815-A551ECD7-443B-43D3-A24E-650C3BD08DCDQ41191159-ABCC4FFF-88B9-4956-8D41-9F0D50D4D602Q43063064-D46C78EA-70E8-4565-9B6A-5BBD1BF1B48D
P2860
Risk of Upper Gastrointestinal Bleeding in a Cohort of New Users of Low-Dose ASA for Secondary Prevention of Cardiovascular Outcomes.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Risk of Upper Gastrointestinal ...... on of Cardiovascular Outcomes.
@ast
Risk of Upper Gastrointestinal ...... on of Cardiovascular Outcomes.
@en
type
label
Risk of Upper Gastrointestinal ...... on of Cardiovascular Outcomes.
@ast
Risk of Upper Gastrointestinal ...... on of Cardiovascular Outcomes.
@en
prefLabel
Risk of Upper Gastrointestinal ...... on of Cardiovascular Outcomes.
@ast
Risk of Upper Gastrointestinal ...... on of Cardiovascular Outcomes.
@en
P2860
P356
P1476
Risk of Upper Gastrointestinal ...... ion of Cardiovascular Outcomes
@en
P2093
Luis A García Rodríguez
P2860
P356
10.3389/FPHAR.2010.00126
P577
2010-10-14T00:00:00Z